Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001615219-22-000091)

Filing Details

Accession Number:: 0001615219-22-000091
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2022-06-06 20:28:43
Reporting Period:: 2020-02-11

Accepted Time:: 2022-06-06 20:28:43
Original Submission Date:: 2020-02-12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1615219	Salarius Pharmaceuticals Inc.	SLRX	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1233253	C Arnold Hanish	C/O Salarius Pharmaceuticals, Inc. 2450 Holcombe Blvd., Suite X Houston TX 77021		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-02-11	4,350	$1.15	7,350	No	4	P	Indirect	By Arnold C. Hanish Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Arnold C. Hanish Trust

Footnotes

This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on February 12, 2020 to reflect that the securities reported are indirectly beneficially owned as indicated herein.